Renal Cancer Clinical Quality Performance Indicators: Engagement Document

This document is being circulated for comment and feedback in order to ensure wide

engagement with professional groups, health service staff, voluntary organisations, patients affected by renal cancer and the wider public.


1. Active treatment is defined as partial or radical nephrectomy, cryotherapy, radio frequency ablation or systemic therapy
2. Valid prognostic scoring can be assigned using various models including MSKCC/Motzer, or Heng scoring tools.
3. Advanced/ metastatic disease defined as T4NanyMany; TanyNanyM1.
4. Systemic anti-cancer treatments will include any drug which is licensed in this indication; the accompanying data standard contains relevant information about appropriate treatments.


Back to top